Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Dengue vaccine poised for roll-out but safety concerns linger

Access options

Rent or buy this article

Get just this article for as long as you need it


Prices may be subject to local taxes which are calculated during checkout

Nature 611, 434-435 (2022)


Updates & Corrections

  • Correction 11 November 2022: A previous version of this story incorrectly stated that Qdenga was an inactivated-virus vaccine. It is a live attenuated vaccine.


  1. Biswal, S. et al. N. Engl. J. Med. 381, 2009–2019 (2019).

    Article  PubMed  Google Scholar 

  2. Halstead, S. B. J. Infect. Dis. 214, 1793–1795 (2016).

    Article  PubMed  Google Scholar 

  3. Sridhar, S. et al. N. Engl. J. Med. 379, 327–340 (2018).

    Article  PubMed  Google Scholar 

  4. Rivera, L. et al. Clin. Infect. Dis. 75, 107–117 (2022).

    Article  PubMed  Google Scholar 

Download references


Nature Careers


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing


Quick links